Literature DB >> 31509603

Pre-exposure Prophylaxis Persistence Is a Critical Issue in PrEP Implementation.

Matthew A Spinelli1,2, Susan P Buchbinder1,2,3.   

Abstract

Keywords:  HIV; MSM; PrEP; Pre-exposure prophylaxis; persistence

Year:  2020        PMID： 31509603      PMCID： PMC7384308          DOI： 10.1093/cid/ciz896

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  18 in total

1.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

Review 2.  Implementation Strategies to Increase PrEP Uptake in the South.

Authors:  Patrick S Sullivan; Leandro Mena; Latesha Elopre; Aaron J Siegler
Journal:  Curr HIV/AIDS Rep       Date:  2019-08       Impact factor: 5.071

3.  Effective use of pre-exposure prophylaxis (PrEP) Among stimulant users with multiple condomless sex partners: a longitudinal study of men who have sex with men in Los Angeles.

Authors:  David Goodman-Meza; Matthew R Beymer; Ryan M Kofron; K Rivet Amico; Christina Psaros; Lane R Bushman; Peter L Anderson; Robert Bolan; Wilbert C Jordan; James F Rooney; Amy R Wohl; Raphael J Landovitz
Journal:  AIDS Care       Date:  2019-03-20

4.  Development and validation of an automated HIV prediction algorithm to identify candidates for pre-exposure prophylaxis: a modelling study.

Authors:  Douglas S Krakower; Susan Gruber; Katherine Hsu; John T Menchaca; Judith C Maro; Benjamin A Kruskal; Ira B Wilson; Kenneth H Mayer; Michael Klompas
Journal:  Lancet HIV       Date:  2019-07-05       Impact factor: 12.767

5.  Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.

Authors:  Jean-Michel Molina; Isabelle Charreau; Bruno Spire; Laurent Cotte; Julie Chas; Catherine Capitant; Cecile Tremblay; Daniela Rojas-Castro; Eric Cua; Armelle Pasquet; Camille Bernaud; Claire Pintado; Constance Delaugerre; Luis Sagaon-Teyssier; Soizic Le Mestre; Christian Chidiac; Gilles Pialoux; Diane Ponscarme; Julien Fonsart; David Thompson; Mark A Wainberg; Veronique Doré; Laurence Meyer
Journal:  Lancet HIV       Date:  2017-07-23       Impact factor: 12.767

Review 6.  Next-Wave HIV Pre-Exposure Prophylaxis Implementation for Gay and Bisexual Men.

Authors:  Sarit A Golub; Julie E Myers
Journal:  AIDS Patient Care STDS       Date:  2019-05-16       Impact factor: 5.078

7.  Racial/ethnic and HIV risk category disparities in preexposure prophylaxis discontinuation among patients in publicly funded primary care clinics.

Authors:  Hyman M Scott; Matthew Spinelli; Eric Vittinghoff; Alicia Morehead-Gee; Anne Hirozawa; Catherine James; Hali Hammer; Albert Liu; Monica Gandhi; Susan Buchbinder
Journal:  AIDS       Date:  2019-11-15       Impact factor: 4.177

8.  Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study.

Authors:  Andrew E Grulich; Rebecca Guy; Janaki Amin; Fengyi Jin; Christine Selvey; Jo Holden; Heather-Marie A Schmidt; Iryna Zablotska; Karen Price; Bill Whittaker; Kerry Chant; Craig Cooper; Scott McGill; Barbara Telfer; Barbara Yeung; Gesalit Levitt; Erin E Ogilvie; Nila J Dharan; Mohamed A Hammoud; Stefanie Vaccher; Lucy Watchirs-Smith; Anna McNulty; David J Smith; Debra M Allen; David Baker; Mark Bloch; Rohan I Bopage; Katherine Brown; Andrew Carr; Christopher J Carmody; Kym L Collins; Robert Finlayson; Rosalind Foster; Eva Y Jackson; David A Lewis; Josephine Lusk; Catherine C O'Connor; Nathan Ryder; Emanuel Vlahakis; Phillip Read; David A Cooper
Journal:  Lancet HIV       Date:  2018-10-17       Impact factor: 12.767

9.  Preexposure prophylaxis guidelines have low sensitivity for identifying seroconverters in a sample of young Black MSM in Chicago.

Authors:  Nicola Lancki; Ellen Almirol; Leigh Alon; Moira McNulty; John A Schneider
Journal:  AIDS       Date:  2018-01-28       Impact factor: 4.177

10.  Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities.

Authors:  Philip A Chan; Leandro Mena; Rupa Patel; Catherine E Oldenburg; Laura Beauchamps; Amaya G Perez-Brumer; Sharon Parker; Kenneth H Mayer; Matthew J Mimiaga; Amy Nunn
Journal:  J Int AIDS Soc       Date:  2016-06-13       Impact factor: 5.396
View more
  9 in total

1.  Casting a Wide Net: HIV Drug Resistance Monitoring in Pre-Exposure Prophylaxis Seroconverters in the Global Evaluation of Microbicide Sensitivity Project.

Authors:  Lisa Levy; Jill M Peterson; Lauren D Kudrick; Bhavna Chohan; Everline Bosek; Irene Mukui; Mary Mugambi; Sarah Masyuko; Owen Mugurungi; Nonhlanhla Ndlovu; Imelda Mahaka; Megan Dunbar; Anita Hettema; Rudo A P Kuwengwa; Sindy Matse; Saiqa Mullick; Letitia Greener; Cara O'Connor; Diantha Pillay; Maria Fawzy; John W Mellors; Urvi M Parikh
Journal:  Glob Health Sci Pract       Date:  2022-04-29

2.  "Do I want PrEP or do I want a roof?": Social determinants of health and HIV prevention in the southern United States.

Authors:  Sayward E Harrison; Mariajosé Paton; Kathryn E Muessig; Alyssa C Vecchio; Lyd A Hanson; Lisa B Hightow-Weidman
Journal:  AIDS Care       Date:  2022-02-02

3.  Eliciting Preferences for HIV Prevention Technologies: A Systematic Review.

Authors:  S Wilson Beckham; Norah L Crossnohere; Margaret Gross; John F P Bridges
Journal:  Patient       Date:  2020-12-15       Impact factor: 3.883

4.  Characterization of HIV Preexposure Prophylaxis Use Behaviors and HIV Incidence Among US Adults in an Integrated Health Care System.

Authors:  J Carlo Hojilla; Leo B Hurley; Julia L Marcus; Michael J Silverberg; Jacek Skarbinski; Derek D Satre; Jonathan E Volk
Journal:  JAMA Netw Open       Date:  2021-08-02

5.  Acceptability of the Dapivirine Vaginal Ring in Postmenopausal US Women.

Authors:  Mary Kate Shapley-Quinn; Nicole Laborde; Ellen Luecke; Craig Hoesley; Robert A Salata; Sherri Johnson; Annalene Nel; Lydia Soto-Torres; Beatrice A Chen; Ariane van der Straten
Journal:  AIDS Patient Care STDS       Date:  2022-03       Impact factor: 5.944

Review 6.  Roll-out of HIV pre-exposure prophylaxis: a gateway to mental health promotion.

Authors:  Daniel J Ikeda; Khameer Kidia; Bruce D Agins; Jessica E Haberer; Alexander C Tsai
Journal:  BMJ Glob Health       Date:  2021-12

7.  Why Do HIV Pre-Exposure Prophylaxis Users Discontinue Pre-Exposure Prophylaxis Care? A Mixed Methods Survey in a Pre-Exposure Prophylaxis Clinic in Belgium.

Authors:  Thibaut Vanbaelen; Anke Rotsaert; Bart K M Jacobs; Eric Florence; Chris Kenyon; Bea Vuylsteke; Marie Laga; Reyniers Thijs
Journal:  AIDS Patient Care STDS       Date:  2022-04       Impact factor: 5.944

8.  Facilitators for retaining men who have sex with men in pre-exposure prophylaxis care in real world clinic settings within the United States.

Authors:  Brooke G Rogers; C Sosnowy; A Zanowick-Marr; P A Chan; L A Mena; R R Patel; W C Goedel; T Arnold; C Chu; D Galipeau; M C Montgomery; K Curoe; A Underwood; J Villalobos; C Gomillia; A S Nunn
Journal:  BMC Infect Dis       Date:  2022-08-05       Impact factor: 3.667

9.  The importance of PrEP persistence in preventing HIV infections on PrEP.

Authors:  Matthew A Spinelli; Nicole Laborde; Patrick Kinley; Ryan Whitacre; Hyman M Scott; Nicole Walker; Albert Y Liu; Monica Gandhi; Susan P Buchbinder
Journal:  J Int AIDS Soc       Date:  2020-08       Impact factor: 5.396
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.